BRPI0807798A2 - " aperfeiçoamento do crescimento celular ". - Google Patents

" aperfeiçoamento do crescimento celular ".

Info

Publication number
BRPI0807798A2
BRPI0807798A2 BRPI0807798-3A2A BRPI0807798A BRPI0807798A2 BR PI0807798 A2 BRPI0807798 A2 BR PI0807798A2 BR PI0807798 A BRPI0807798 A BR PI0807798A BR PI0807798 A2 BRPI0807798 A2 BR PI0807798A2
Authority
BR
Brazil
Prior art keywords
improvement
cell growth
growth
cell
Prior art date
Application number
BRPI0807798-3A2A
Other languages
English (en)
Inventor
Hitto Kaufmann
Lore Florin
Eric Becker
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of BRPI0807798A2 publication Critical patent/BRPI0807798A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
    • C12N9/0028—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
    • C12N9/003—Dihydrofolate reductase [DHFR] (1.5.1.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
BRPI0807798-3A2A 2007-01-24 2008-01-22 " aperfeiçoamento do crescimento celular ". BRPI0807798A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07101070A EP1953222A1 (en) 2007-01-24 2007-01-24 Improvement of cell growth
PCT/EP2008/050699 WO2008090148A2 (en) 2007-01-24 2008-01-22 Improvement of cell growth

Publications (1)

Publication Number Publication Date
BRPI0807798A2 true BRPI0807798A2 (pt) 2014-06-03

Family

ID=38006916

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0807798-3A2A BRPI0807798A2 (pt) 2007-01-24 2008-01-22 " aperfeiçoamento do crescimento celular ".

Country Status (13)

Country Link
US (1) US8535940B2 (pt)
EP (2) EP1953222A1 (pt)
JP (1) JP2010516264A (pt)
KR (1) KR20090112725A (pt)
CN (1) CN101589140B (pt)
AU (1) AU2008208862B2 (pt)
BR (1) BRPI0807798A2 (pt)
CA (1) CA2675344A1 (pt)
EA (1) EA018099B1 (pt)
IL (1) IL199639A (pt)
MX (1) MX2009007790A (pt)
NZ (1) NZ579204A (pt)
WO (1) WO2008090148A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1953222A1 (en) 2007-01-24 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Improvement of cell growth
WO2010010108A1 (en) * 2008-07-23 2010-01-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Improved production host cell lines
CN102333875B (zh) 2009-02-27 2014-04-16 诺华股份有限公司 选择表达异源蛋白质的真核细胞的方法
CN104919046A (zh) 2012-12-10 2015-09-16 生化学工业株式会社 新重组因子c、其制造方法、及内毒素的测定法
AU2015345943B2 (en) * 2014-11-12 2020-03-19 Liminal Biosciences Limited Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration
CN107119018B (zh) * 2017-03-30 2020-08-18 陕西师范大学 一种抗凋亡细胞系及其建立方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59010941D1 (de) 1989-04-21 2005-03-24 Amgen Inc TNF-Rezeptor, TNF bindende Proteine und dafür kodierende DNAs
US6221675B1 (en) * 1989-04-21 2001-04-24 Amgen, Inc. TNF receptors, TNF binding proteins and DNAs coding for them
US5776746A (en) * 1996-05-01 1998-07-07 Genitope Corporation Gene amplification methods
EP1348758A1 (en) * 2002-03-28 2003-10-01 Boehringer Ingelheim Pharma GmbH & Co.KG Host cells having improved cell survival properties and methods to generate such cells
US20030219871A1 (en) 2002-03-28 2003-11-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Host cells having improved cell survival properties and methods to generate such cells
EP1953222A1 (en) 2007-01-24 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Improvement of cell growth

Also Published As

Publication number Publication date
AU2008208862A1 (en) 2008-07-31
CN101589140A (zh) 2009-11-25
AU2008208862B2 (en) 2014-05-08
KR20090112725A (ko) 2009-10-28
HK1137482A1 (en) 2010-07-30
IL199639A0 (en) 2010-04-15
NZ579204A (en) 2012-04-27
WO2008090148A3 (en) 2008-09-18
JP2010516264A (ja) 2010-05-20
EP2126061A2 (en) 2009-12-02
EA018099B1 (ru) 2013-05-30
US8535940B2 (en) 2013-09-17
WO2008090148A2 (en) 2008-07-31
CA2675344A1 (en) 2008-07-31
CN101589140B (zh) 2013-04-17
IL199639A (en) 2013-08-29
EP1953222A1 (en) 2008-08-06
EA200900984A1 (ru) 2010-02-26
MX2009007790A (es) 2009-07-31
US20100086967A1 (en) 2010-04-08

Similar Documents

Publication Publication Date Title
BRPI0716762A2 (pt) melhorias da cultura celular
BRPI0818536A2 (pt) Linhagem celular cho-k1
CL2007002310S1 (es) Telefono celular.
PL2634242T3 (pl) Ulepszony sposób hodowli komórek
BR112012000735A2 (pt) "métodos, kits e conjuntos de compostos"
EP2213856A4 (en) AUSPUFFROHR
EP2115141A4 (en) miRNA FROM INVERTEBRATES
EP1958592A4 (en) intraocular lens
BRPI0814894A2 (pt) Diferenciação de células-tronco embrionárias de ser humano.
LT3320912T (lt) Indolamino 2,3-dioksigenaze grindžiama imunoterapija
BRPI0913806A2 (pt) "composição"
BRPI0816970A2 (pt) 1,3-dissubstituídas-4-fenil-1h-piridin-2-onas
EP1882736A4 (en) CELL CULTURE CONTAINER
BRPI0820145A2 (pt) "vestimenta"
MA30948B1 (fr) MYRTILLE NOMME " DrisBlueThree "
BRPI0714209A2 (pt) Induzidor de morte celular
EP2192862A4 (en) DOUBLE DRIVE FOR MILLERS
IT1392533B1 (it) Composizione di aerosol con supporto acquoso.
DE602006014483D1 (de) Gewebekulturmikroskop
DK2119776T3 (da) Dagblomst- flavonoid-3',5'-hydroxylase-gen
FR2939766B1 (fr) Pylone central d'aeronef.
IL199639A0 (en) Improvement of cell growth
BRPI0819979A2 (pt) tratamento de biomassa celular eucariótica
ITGE20050091A1 (it) Incubatrice
EP2117591A4 (en) REDUCING TUMOR GROWTH

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.